ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 30 of 490 for:    Harvard

Sugar Sweetened Beverage Labeling Support

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02947802
Recruitment Status : Completed
First Posted : October 28, 2016
Last Update Posted : February 23, 2017
Sponsor:
Information provided by (Responsible Party):
Grant Donnelly, Harvard University

Brief Summary:
This is an online survey assessing consumer support for different labeling policies related to sugar sweetened beverages. The investigators will present consumers with three labels that are being considered for sugar sweetened beverages: a calorie label, a text warning label that says "Warning drinking beverages with added sugar(s) can lead to health problems like obesity, diabetes and tooth decay" and a graphic warning label that includes graphic images to correspond with each of the health problems listed with the text warning. The investigators will ask participants their support for each label. The investigators will also see if support for the labels change after learning of the effectiveness of these labels. The investigators will share the results of a recent field study that suggested calorie and textual warning labels had no influence on the purchasing of sugar sweetened beverages while the graphic label decreased purchasing by 11 percent.

Condition or disease Intervention/treatment Phase
Consumer Behavior Other: Effectiveness of Labels in Reducing Purchasing of Sugar Sweetened Beverages Other: Control condition Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 400 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Basic Science
Official Title: Sugar Sweetened Beverage Labeling Support
Study Start Date : October 2016
Actual Primary Completion Date : November 2016
Actual Study Completion Date : November 2016

Arm Intervention/treatment
Experimental: Consumer Support
Participants will be presented with three labels: a calorie label, a textual warning label and a textual warning label with corresponding graphic images and will be asked to rate their support for each label on a 1 (not at all) to 7 (a great deal) scale.
Other: Control condition
In one of our parallel assigned conditions participants will receive no additional information and be asked to rate their support for the label.

Experimental: Consumer Support with Effectiveness Info
Participants will be presented with three labels: a calorie label, a textual warning label and a textual warning label with corresponding graphic images and will be asked to rate their support for each label on a 1 (not at all) to 7 (a great deal) scale. Participants will also receive effectiveness information- how each label influenced the purchasing of sugar sweetened beverages- from a recent field experiment.
Other: Effectiveness of Labels in Reducing Purchasing of Sugar Sweetened Beverages
In one of our parallel assigned conditions participants will receive additional information (e.g., an intervention) of effectiveness information. These consumers will learn how effective these labels were in reducing the purchasing of sugar sweetened beverages in a recent study.




Primary Outcome Measures :
  1. Rate Support of a Label on a 1 (not at all) to 7 (a great deal) Scale. [ Time Frame: Immediately following the presentation of the labels. ]
    Participants will rate their support of the label on a 1 (not at all) to 7 (a great deal)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • The investigators will recruit a nationally representative sample using ClearVoice, a company that recruits online survey takers.

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02947802


Locations
United States, Massachusetts
Harvard University
Cambridge, Massachusetts, United States, 02163
Sponsors and Collaborators
Harvard University

Study Data/Documents: Study Instrument (Online Survey)  This link exits the ClinicalTrials.gov site
This is the online survey participants will complete.

Responsible Party: Grant Donnelly, Doctoral Student, Harvard University
ClinicalTrials.gov Identifier: NCT02947802     History of Changes
Other Study ID Numbers: IRB16-1585
First Posted: October 28, 2016    Key Record Dates
Last Update Posted: February 23, 2017
Last Verified: February 2017